212 related articles for article (PubMed ID: 32640214)
1. Mutant p53 Drives Cancer Metastasis via RCP-Mediated Hsp90α Secretion.
Zhang S; Wang C; Ma B; Xu M; Xu S; Liu J; Tian Y; Fu Y; Luo Y
Cell Rep; 2020 Jul; 32(1):107879. PubMed ID: 32640214
[TBL] [Abstract][Full Text] [Related]
2. The activating transcription factor 3 protein suppresses the oncogenic function of mutant p53 proteins.
Wei S; Wang H; Lu C; Malmut S; Zhang J; Ren S; Yu G; Wang W; Tang DD; Yan C
J Biol Chem; 2014 Mar; 289(13):8947-59. PubMed ID: 24554706
[TBL] [Abstract][Full Text] [Related]
3. Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment.
Alexandrova EM; Yallowitz AR; Li D; Xu S; Schulz R; Proia DA; Lozano G; Dobbelstein M; Moll UM
Nature; 2015 Jul; 523(7560):352-6. PubMed ID: 26009011
[TBL] [Abstract][Full Text] [Related]
4. Mutant p53 drives invasion by promoting integrin recycling.
Muller PA; Caswell PT; Doyle B; Iwanicki MP; Tan EH; Karim S; Lukashchuk N; Gillespie DA; Ludwig RL; Gosselin P; Cromer A; Brugge JS; Sansom OJ; Norman JC; Vousden KH
Cell; 2009 Dec; 139(7):1327-41. PubMed ID: 20064378
[TBL] [Abstract][Full Text] [Related]
5. SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis.
Li D; Marchenko ND; Moll UM
Cell Death Differ; 2011 Dec; 18(12):1904-13. PubMed ID: 21637290
[TBL] [Abstract][Full Text] [Related]
6. Allele-specific silencing of mutant p53 attenuates dominant-negative and gain-of-function activities.
Iyer SV; Parrales A; Begani P; Narkar A; Adhikari AS; Martinez LA; Iwakuma T
Oncotarget; 2016 Feb; 7(5):5401-15. PubMed ID: 26700961
[TBL] [Abstract][Full Text] [Related]
7. Metformin Inhibits Tumor Metastasis through Suppressing Hsp90α Secretion in an AMPKα1-PKCγ Dependent Manner.
Gong Y; Wang C; Jiang Y; Zhang S; Feng S; Fu Y; Luo Y
Cells; 2020 Jan; 9(1):. PubMed ID: 31936169
[TBL] [Abstract][Full Text] [Related]
8. Tumour-Secreted Hsp90α on External Surface of Exosomes Mediates Tumour - Stromal Cell Communication via Autocrine and Paracrine Mechanisms.
Tang X; Chang C; Guo J; Lincoln V; Liang C; Chen M; Woodley DT; Li W
Sci Rep; 2019 Oct; 9(1):15108. PubMed ID: 31641193
[TBL] [Abstract][Full Text] [Related]
9. Mutant p53 promotes RCP-dependent chemoresistance coinciding with increased delivery of P-glycoprotein to the plasma membrane.
Phatak V; von Grabowiecki Y; Janus J; Officer L; Behan C; Aschauer L; Pinon L; Mackay H; Zanivan S; Norman JC; Kelly M; Le Quesne J; Muller PAJ
Cell Death Dis; 2021 Feb; 12(2):207. PubMed ID: 33627632
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Ablation of Gain-of-Function Mutant p53 in Colorectal Cancer Inhibits Stat3-Mediated Tumor Growth and Invasion.
Schulz-Heddergott R; Stark N; Edmunds SJ; Li J; Conradi LC; Bohnenberger H; Ceteci F; Greten FR; Dobbelstein M; Moll UM
Cancer Cell; 2018 Aug; 34(2):298-314.e7. PubMed ID: 30107178
[TBL] [Abstract][Full Text] [Related]
11. Secretion of extracellular hsp90alpha via exosomes increases cancer cell motility: a role for plasminogen activation.
McCready J; Sims JD; Chan D; Jay DG
BMC Cancer; 2010 Jun; 10():294. PubMed ID: 20553606
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic Cancer Progression Relies upon Mutant p53-Induced Oncogenic Signaling Mediated by NOP14.
Du Y; Liu Z; You L; Hou P; Ren X; Jiao T; Zhao W; Li Z; Shu H; Liu C; Zhao Y
Cancer Res; 2017 May; 77(10):2661-2673. PubMed ID: 28280038
[TBL] [Abstract][Full Text] [Related]
13. TRRAP is essential for regulating the accumulation of mutant and wild-type p53 in lymphoma.
Jethwa A; Słabicki M; Hüllein J; Jentzsch M; Dalal V; Rabe S; Wagner L; Walther T; Klapper W; ; Bohnenberger H; Rettel M; Lu J; Smits AH; Stein F; Savitski MM; Huber W; Aylon Y; Oren M; Zenz T
Blood; 2018 Jun; 131(25):2789-2802. PubMed ID: 29653964
[TBL] [Abstract][Full Text] [Related]
14. DNAJA1 promotes cancer metastasis through interaction with mutant p53.
Kaida A; Yamamoto S; Parrales A; Young ED; Ranjan A; Alalem MA; Morita KI; Oikawa Y; Harada H; Ikeda T; Thomas SM; Diaz FJ; Iwakuma T
Oncogene; 2021 Aug; 40(31):5013-5025. PubMed ID: 34183772
[TBL] [Abstract][Full Text] [Related]
15. Proteomic identification of heat shock protein 90 as a candidate target for p53 mutation reactivation by PRIMA-1 in breast cancer cells.
Rehman A; Chahal MS; Tang X; Bruce JE; Pommier Y; Daoud SS
Breast Cancer Res; 2005; 7(5):R765-74. PubMed ID: 16168122
[TBL] [Abstract][Full Text] [Related]
16. Mutant p53-ENTPD5 control of the calnexin/calreticulin cycle: a druggable target for inhibiting integrin-α5-driven metastasis.
Pavlakis E; Neumann M; Merle N; Wieboldt R; Wanzel M; Ponath V; Pogge von Strandmann E; Elmshäuser S; Stiewe T
J Exp Clin Cancer Res; 2023 Aug; 42(1):203. PubMed ID: 37563605
[TBL] [Abstract][Full Text] [Related]
17. Mutant p53s generate pro-invasive niches by influencing exosome podocalyxin levels.
Novo D; Heath N; Mitchell L; Caligiuri G; MacFarlane A; Reijmer D; Charlton L; Knight J; Calka M; McGhee E; Dornier E; Sumpton D; Mason S; Echard A; Klinkert K; Secklehner J; Kruiswijk F; Vousden K; Macpherson IR; Blyth K; Bailey P; Yin H; Carlin LM; Morton J; Zanivan S; Norman JC
Nat Commun; 2018 Nov; 9(1):5069. PubMed ID: 30498210
[TBL] [Abstract][Full Text] [Related]
18. DNAJA1 controls the fate of misfolded mutant p53 through the mevalonate pathway.
Parrales A; Ranjan A; Iyer SV; Padhye S; Weir SJ; Roy A; Iwakuma T
Nat Cell Biol; 2016 Nov; 18(11):1233-1243. PubMed ID: 27775703
[TBL] [Abstract][Full Text] [Related]
19. Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246.
Cooks T; Pateras IS; Jenkins LM; Patel KM; Robles AI; Morris J; Forshew T; Appella E; Gorgoulis VG; Harris CC
Nat Commun; 2018 Feb; 9(1):771. PubMed ID: 29472616
[TBL] [Abstract][Full Text] [Related]
20. PLCγ1-PKCγ signaling-mediated Hsp90α plasma membrane translocation facilitates tumor metastasis.
Yang J; Song X; Chen Y; Lu XA; Fu Y; Luo Y
Traffic; 2014 Aug; 15(8):861-78. PubMed ID: 24899266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
